Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
作者信息
Conway Richard, O'Donnell Rory, Fahy Ruairi, Doran Michele F, Cunnane Gaye, O'Shea Finbar D
机构信息
Departments of Rheumatology and Respiratory Medicine, St. James Hospital, Dublin 8, Ireland. email:
出版信息
QJM. 2014 Jul;107(7):593-4. doi: 10.1093/qjmed/hct246. Epub 2013 Dec 11.
PMID:24336848
Abstract
摘要
相似文献
1
Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
QJM. 2014 Jul;107(7):593-4. doi: 10.1093/qjmed/hct246. Epub 2013 Dec 11.
2
Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.
Scand J Rheumatol. 2018 Jul;47(4):334-335. doi: 10.1080/03009742.2017.1369155. Epub 2017 Oct 18.
3
Three cases of autoimmune-associated haemophagocytic syndrome in dermatomyositis with anti-MDA5 autoantibody.
Scand J Rheumatol. 2020 May;49(3):244-246. doi: 10.1080/03009742.2019.1653493. Epub 2019 Oct 1.
4
Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis.
Sarcoidosis Vasc Diffuse Lung Dis. 2002 Jun;19(2):128-33.
5
Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.
Int J Rheum Dis. 2017 Dec;20(12):2182-2185. doi: 10.1111/1756-185X.13136. Epub 2017 Jul 27.
6
Spontaneous pneumomediastinum in a dermatomyositis patient with anti-melanoma differentiation-associated gene-5 antibody and interstitial lung disease despite an initial response to immunosuppressant.
Int J Rheum Dis. 2019 Mar;22(3):521-524. doi: 10.1111/1756-185X.13112. Epub 2017 Jun 4.
7
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Mod Rheumatol Case Rep. 2021 Jan;5(1):101-107. doi: 10.1080/24725625.2020.1832755. Epub 2020 Oct 20.
8
Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy.
Intern Med. 1997 Jul;36(7):519-23. doi: 10.2169/internalmedicine.36.519.
9
Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis.
Rheumatology (Oxford). 2021 Jul 1;60(7):e227-e228. doi: 10.1093/rheumatology/keaa906.
10
Evolution of clinically amyopathic dermatomyositis despite aggressive immunosuppression with cyclophosphamide and prednisone.
J Clin Rheumatol. 2010 Apr;16(3):143-5. doi: 10.1097/RHU.0b013e3181d59c59.
引用本文的文献
1
Rapid progressive interstitial lung disease as initial manifestation of primary Sjögren's syndrome: a case report.
Int J Clin Exp Med. 2014 Dec 15;7(12):5904-8. eCollection 2014.
Zotero 插件